Table 1.
Univariate analysis of the strains of carbapenem-resistant Enterobacteriaceae (CRE) in patients with or without concomitant SARS-CoV-2 (COVID-19) that were included in a retrospective case–control study that aimed to identify the strains of CRE and the risk factors associated with acquiring these infections.
| Isolates with CRE strains | Patients with COVID-19n = 38 | Patients without COVID-19n = 26 |
|---|---|---|
| CRE colonization | 30 (78.95) | 22 (84.62) |
| CRE infection | 16 (42.11) | 5 (19.23) |
Data presented as n of patients (%).
No significant between-group differences (P > 0.05); χ2-test.